Last reviewed · How we verify

NCT06240702

Effects of Early Telerehabilitation in Coronary Artery Bypass Surgery Patients

Completed NA Last updated 12 November 2024
What this trial tests

NA trial testing Telerehabilitation Group in Coronary Artery Disease in 40 participants. Completed in 4 November 2024.

Timeline
20 April 2024
Primary endpoint
20 August 2024
4 November 2024

Quick facts

Lead sponsorNecmettin Erbakan University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date20 April 2024
Primary completion20 August 2024
Estimated completion4 November 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Necmettin Erbakan University

Who can join

Adults 45 to 75, any sex, with Coronary Artery Disease or Cardiac Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to investigate the effects of phase I and early phase II rehabilitation with telerehabilitation method and sleep hygiene training on physical capacity, cardiac functions, anxiety level, quality of life and sleep quality in patients undergoing coronary artery bypass graft surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Telerehabilitation Group

Trials testing the same drug.

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Necmettin Erbakan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06240702.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing